HealthBreaking8 hr ago

Blood pressure medication recalled in 3,700 bottles after failed dissolution testing

Coverage spectrum

Covered by 3 outlets, mostly right-leaning (67%).

3 articles in total. The spectrum counts each outlet once and leaves opinion out. How we measure bias

The Food and Drug Administration has listed a recall of about 3,700 bottles of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Tablets, a blood pressure medication, in its enforcement report. The report lists Macleods Pharma USA as having initiated the recall on Oct. 7 and classifies it as Class II, which the FDA describes as a remote probability of serious adverse health consequences. The stated reason is failed dissolution specifications, meaning the pills did not dissolve as required in testing. According to the same report, the affected lots were distributed nationwide between Nov. 21, 2025 and April 27, 2026.

Headline and summary written by Mantle’s AI from the coverage below, under published rules. Editors read every story. How this works

New to Mantle? It shows who is covering each story across the political spectrum, and highlights loaded words. How to read a storyHide the guide

The coverage spectrum counts the outlets covering a story at each of five points. A short or missing segment means that part of the spectrum is mostly quiet.

Governor Loaded verb“slams”It adds drama to what was said. The governor criticized the lawmakers; “slams” makes it sound like a fight.More neutral: criticizes lawmakers over budget delay

Highlights mark words that carry a judgement. Tap one to see why, and what a neutral writer would say. Here it is “criticizes”.

The 5-point spectrum

Far Left
Voices that strongly advocate for progressive policies and systemic change.
Left
Mainstream liberal perspectives focusing on social equality and regulation.
Center
Sources that prioritize neutral reporting and balanced viewpoints.
Right
Mainstream conservative perspectives focusing on market freedom and tradition.
Far Right
Voices that strongly advocate for conservative values and limited government.

How we measure bias

What happened

Key points

Each point shows who reports it, from Far Left to Far Right.

The FDA has listed a recall of about 3,700 bottles of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Tablets, a blood pressure medication.
Reported byCenter1Right2See the outletsHide the outlets
Center
NewsNation
Right
The Washington Times, New York Post
The FDA lists the reason for the recall as failed dissolution specifications, meaning the pills did not dissolve as required in testing.
Reported byCenter1Right1See the outletsHide the outlets
Center
NewsNation
Right
New York Post
The FDA classified the recall as Class II, which it describes as a remote probability of serious adverse health consequences.
Reported byCenter1Right1See the outletsHide the outlets
Center
NewsNation
Right
New York Post
The FDA report lists Macleods Pharma USA as having initiated the recall on Oct. 7.
Reported byCenter1Right1See the outletsHide the outlets
Center
NewsNation
Right
New York Post
According to the enforcement report, the affected lots were distributed nationwide between Nov. 21, 2025 and April 27, 2026.
One outletNewsNation· Center

How each side tells it

Compare views

All three outlets report the FDA-listed recall of about 3,700 bottles of a blood pressure medication. NewsNation frames it around efficacy concerns, while the right-side outlets stress failed dissolution testing and urge consumers to check their bottles.

the left
No coverage yet
No left-leaning outlet that Mantle follows has covered this story yet. That absence is part of the picture.
the center
1 outlet
NewsNation's headline frames the recall around efficacy concerns and calls the medication popular, without naming the company.
Popular blood pressure medication recalled over efficacy concerns
NewsNationCenterAll center headlines
the right
2 outlets
Right-side headlines stress the recall as failed quality testing and nationwide risk; the New York Post item is a Fox Business report, and the Washington Times headline credits the FDA with the recall.
FDA issues recall for 3,700 bottles of blood pressure medication
The Washington TimesRightAll right-leaning headlines

The words they chose

Language to notice

Words that carry a judgement beyond the facts. Tap a highlighted word anywhere on the page to see why.

Mantle found no loaded language in this coverage. Every headline and opening was checked against Mantle’s published word list, and Mantle’s AI read all 3 articles in context. Straight reporting often has none.

See for yourself

Side by side

What each side leads with and what it leaves out. Open a side to read its headlines.

From the left

0 outlets

No left-leaning outlet that Mantle follows has covered this story yet. That absence is part of the picture.

From the center

1 outlet

Leads with

Efficacy concerns as the reason for the recall
Popularity of the medication
Voluntary action by a pharmaceutical company

Leaves out

Lot numbers and NDC codes for consumers to check their bottles

Reported by other sides, not found in this side’s coverage.

See the headline from the centerHide the headlines

NewsNationCenter
Popular blood pressure medication recalled over efficacy concerns
(NewsNation) — A pharmaceutical company is voluntarily recalling over 3,700 bottles of blood pressure medication because of efficacy concerns, federal regulators announced last month. The U.S. …
4 hr agoRead at NewsNation (opens in a new tab)

From the right

2 outlets

Leads with

Failed quality or dissolution testing
Nationwide reach of the recall
Advice to consumers to check their medicine cabinets

Leaves out

That the company initiated the recall voluntarily

Reported by other sides, not found in this side’s coverage.

See the 2 headlines from the rightHide the headlines

The Washington TimesRight
FDA issues recall for 3,700 bottles of blood pressure medication
The Food and Drug Administration recalled more than 3,700 bottles of blood pressure medication that were deemed ineffective.
4 hr agoRead at The Washington Times (opens in a new tab)
New York PostRightFox Business report
Thousands of blood pressure medication bottles recalled nationwide after pills fail quality test
The FDA listed the reason for the recall as 'failed dissolution specifications.'
8 hr agoRead at New York Post (opens in a new tab)

The stories you read build My Mix, a private picture of which sides cover the stories you choose, kept on this device. What is My Mix?

The left is Far Left and Left together. The right is Right and Far Right together. Every outlet keeps its own five-point rating.

Who reported it when

How the coverage built up

Left
No report yet
From the outlets Mantle follows
Center
4 hr 32 min later
Its first report, Nov 3, 10:09 AM EST
Right
First to report
New York Post, Nov 3, 5:37 AM EST

See the order the outlets reported inHide the order

New York PostRightNov 3, 5:37 AM EST
NewsNationCenterNov 3, 10:09 AM EST
The Washington TimesRightNov 3, 10:15 AM EST

Times are the ones the outlets published in their own feeds, in Eastern time. Opinion is left out.

Blood pressure medication recalled in 3,700 bottles after failed dissolution testing

Coverage spectrum

Key points

Compare views

the left

the center

the right

Language to notice

Side by side

From the left

From the center

Popular blood pressure medication recalled over efficacy concerns

From the right

FDA issues recall for 3,700 bottles of blood pressure medication

Thousands of blood pressure medication bottles recalled nationwide after pills fail quality test

How the coverage built up

Read next

Washington resident dies of bird flu after exposure to infected cattle

Child dies of measles in New York, the state’s first such death in 30 years

Trump says US will end about $4 billion in aid to Israel by year-end

US strikes Iran’s Qeshm Island a day before midterm elections, officials say

Trump says he would offer preemptive pardons to aides if Democrats win Congress